![Katarina Luptakova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katarina Luptakova
Nessuna posizione attualmente
Patrimonio netto: 22 753 $ in data 30/06/2026
Profilo
Katarina Luptakova worked at Tesaro, Inc. from 2017 to 2020, serving as Senior Medical Director from 2018 to 2020.
From 2020 to 2021, worked at Constellation Pharmaceuticals, Inc. as Vice President-Clinical Development.
From 2022 to 2023, worked at Xilio Therapeutics, Inc. as Senior Vice President-Medical.
Education includes a doctorate from the University of Commenius.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/01/2026 | 2.375 ( 0,04% ) | 22 753 $ | 30/06/2026 |
Precedenti posizioni note di Katarina Luptakova
| Società | Posizione | Fine |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2021 |
| TESARO INC | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
| XILIO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Katarina Luptakova
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
University of Commenius
 University of Commenius Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
